News & Analysis on Clinical Trial Services & Contract Research And Development
Eversana: Kelly Baker, CFO
By Jenni Spinner
- Last updated on
Kelly Baker has been named CFO of Eversana, a global company providing commercial services to the life-sciences industry. In her new role, she will direct the firm’s financial activity, and lead the platform's investment and growth strategies.
Baker said of her new firm, “Backed by owners who share our vision and values, we are investing in the commercial services and technology solutions that meet our clients’ ever evolving needs. It’s exciting to have a front seat in creating a healthier world for all.”
Baker brings more than 15 years of leadership experience in the healthcare sector, most recently leading finance with the DuPage Medical group. In her previous finance executive leadership role at OptumRx, she led several key acquisition programs; other experience includes equities trading and financial analyst roles at Goldman Sachs.